Greenbrook TMS Corporate Presentation 2023

Greenbrook TMS is a leading behavioral health service delivery platform operating 133 treatment centers across 18 U.S. states, specializing in Transcranial Magnetic Stimulation (TMS) therapy for Major Depressive Disorder and Obsessive Compulsive Disorder. The company has treated over 38,000 unique patients with more than 1.2 million treatments and recently expanded its offerings to include Spravato® (nasal esketamine) for treatment-resistant depression.